Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
now, articles about ebola, the gates foundation, other small biotechs, and who knows what else - but with nothing directly linked to pphm - are the fodder for the weekend edition of hopium.
absolutely shameless.
Yes it does seem shameless. Especially after all the avian bird flu nonsense that didn't come to fruition. Then again with pphm nothing usually does.
PPHM THE COMPANY THAT CRIES WE ARE IN TALKS! All imo.
I guess for one of the few times I was incorrect as pphm didn't make its move. Is this the lowest close of the year? I guess there will be no weekend of hopium. I can only imagine what is going to happen when the CEO who cries partner speaks at the ASM and nothing significant comes out of his mouth once again. I am sure we will get the updates that mgmt and the BOD looked very confident and were smiling etc... and that they can't control the stock price etc... The next boom is that earnings is end of this month which will mean ATM sales at record lows.
PPHM THE COMPANY THAT CRIES WE ARE IN TALKS! All imo.
Looks like pphm is making a move. Could lead to a weekend of hopium. Could this be it?
PPHM THE COMPANY THAT CRIES WE ARE IN TALKS! All imo.
Not too favorable but has its merits.
Peregrine Pharmaceuticals' (NASDAQ:PPHM) lead drug bavituximab, a monoclonal antibody turned I-O, is in Phase III for NSCLC, but critics question improvements following lackluster and unreliable Phase II data and wonder why more robust statistical information is not provided
quite low vol. yesterday and today
Actually yesterdays volume was the highest since OCT 1st.
PPHM THE COMPANY THAT CRIES WE ARE IN TALKS! All imo.
Wow pphm hit another year to date low at $1.27 today continuing its down trend from $55 on March 10, 2000. Mgmt has done a brillint job in keeping the loss over 14 years to roughly 97%. Imagine if they weren't doing a brilliant job.
PPHM THE COMPANY THAT CRIES WE ARE IN TALKS. All imo.
Why does PPHM Management Always REWARD THEMSELVES no matter the situation?
Exactly, it is a joke. A retention bonus for something that happened on their watch! Remember when they actually listed what their compensation was based on and they would be rewarded by how they did. Well they failed on I believe 75% of the objectives. Obviously that was the last time they did that! LOL!
PPHM THE COMPANY THAT CRIES WE ARE IN TALKS! all immi.
What evidence is out there that they (management) care less than you or I about the market cap?
Very Easy. Naming Carlton Johnson as COB was and still is a joke and a slap to shareholders and today at the very least they can name two competent members to the BOD and still have a controlling vote.
PPHM THE COMPANY THAT CRIES WE ARE IN TALKS! All imo.
8am has come and gone once again which means no news and no need to update the 2009 Catalyst update for a Bavi and/or Cotara partnership. Perhaps today pphm will make a huge move to $1.40?
PPHM THE COMPANY WHO CRIES WE ARE IN TALKS! All imo.
Woohoo stock hits another year to date low at $1.29 continue the down trend from 2000 when the stock hit $55! Brilliant job to date from this brilliant mgmt team.
PPHM THE COMPANY WHO CRIES PARTNER! All imo.
cheynew you know better.
Biotech stocks/ Pharma stocks do not move parallel to indexes.
Does this mean that SK the CEO of PPHM is a liar? SK stated that pphm tends to flow with the ebb of the market.
PPHM the company that cries partner. All imo.
A couple of dozen is at least 24
Seriously? please preclinical crap means nothing.
Wow, new year to date low for the company who cried partner! Who said we will never see the $1.20's again?
So basically... wait another Year..!!!
Funny but I thought I read a post in 2009 that stated we would have a deal by the end of that year? I guess that is when the 2009 catalyst newbie mandate started.
We don't even move on news anymore
Why would anyone expect a rise on a non event PR such as preclinical news? Typical 8am PR from mgmt. Cross another catalyst off the great catalyst list as a non factor. Why would anyone care about pre clinical news when it takes 12 years to get to the market? Good thing we are involved with dozens of meaningless collaborations. Wall street definitely turning a deaf ear to the company who cried partner! All imo.
Yes at least I am honest enough to say that I caught that before you responded as that is why message was edited. Anyway you cut it, the price is a complete disaster along with mgmt.'s 10 year performance to date. The only forward splits this stock has seen is mgmt.'s salaries, bonuses and options awards. Very sad indeed. All imo.
"Well if you take into account the RS we are really at about 26 cents pre RS so it is not that far off."
Wrong again!
If you take into account the RS's we're about 0.3 cents/sh.
On second thought not even worth it but I am sure this brilliant mgmt team has some tricks up their sleeves with all their experience in running penny stock companies.
Come on, lemmy! If we were really bad our pps would be under 10 cents.
Well if you take into account the RS we are really at about 26 cents pre RS so it is not that far off.
I wish I had your optimism. Full enrollment by end of 2015 is similar to:
-start Phase III by December 31st
-start bavi / yervoy study end of January / first quarter
-breast cancer publication in near future
-liver results soon
Don't forget partner on board for Bavi and Cotara before phase III protocols and the commercial product by mid 2012.
Even with short interest down they were still able to drop the price by .30 since beginning of Sept.
Well you don't know if the short was coverered with new ATM sales. Will find out in November when Lytle tells us how much he recently sold and how he ripped off shareholders by not selling ATM shares during the 60 million share trading days. All imo.
Steve King became CEO in March 2003
Stock price in March 2003 was $2.90. Nice to see under his leadership in over 11 years the stock price is down over 50%. Great return on investment. Meanwhile all indices near all time highs and King himself stated pphm tends to flow with the ebb of the market and that he hoped to have a commercial product by mid 2012. How is our subsidiary in China doing? Any updates? All imo.
They made a small deal years ago with Merck and now the good ole boys push their mabs through.
So in other words having a partner is definitely favorable. Imagine what a partner would have done with a good mab!
Does anyone know if DTRA ever indicated BAVI's efficacy on HVF's(Lassa, Ebola, etc) from the trials in Galveston and others?
$1.31 price says no. Just like using Bavi for the bird flu. Just noise.
I agree but it was only pointed out after someone stated there wasn't and then when it was pointed out that there was the coverup was that he was aware but it didn't affect the stock price. Pretty lame. If someone is trying to make excuses for mgmt than they should get the story straight but as Judge Judy always says if you tell the truth you don't have to remember telling your story. All imo.
... please, any other discrepancies.. just let us know. We are here to set the facts straight and what do you think the FDA used to fast track Phase III Sunrise? Yes... that very same data that Rob Garnick said was the best he has EVER seen.
LOL! Nice try though. No the FDA did not use the original data . Yes they granted fast track but so what? Cotara has fast track and orphan status. Even the PR submitted by mgmt after the botched trial states very simply that the reconstituted data is not as good as originally reported. Those are the facts. If Garnick still feels this is this best data he has ever seen he sure is hiding it well. Maybe he is trying to spread the word but his cellphone is going in and out. I'm sure shareholders would have loved a higher stock price while selling all those ATM shares. All imo..
Dr. Garnick said that the DATA was "as compelling Phase II data as he had EVER SEEN"...that is enough for me!
Just so newbies don't get fooled by misleading statements please research the above statement on your own and you will find the above statement was made on July 16 2012 before Garnick got egg on his face when the botched trial results were released in September 2012 nulling that data. The reconstituted data to date has us at $1.31 and no partner.
It was already proven that at least one company has also given enrollment numbers when it was hinted that there weren't any. There seems to be a concerted effort to disguise the pitifulness of the stock price which is at a year to date low despite being run by a brilliant mgmt team. SK's words to date have been worthless. He is now over two years late on his hoping to bring a commercial product by mid 2012. He is close to becoming the CEO who cried partnerships/collaborations. It is time for mgmt to spread the word if there is any. All imo.
Dr. Garnick said that the DATA was "as compelling Phase II data as he had EVER SEEN"...that is enough for me!
You forgot to add that the above statement was made on July 16 2012 before Garnick got egg on his face when the botched trial results were released in September 2012 nulling that data. All imo.
For those of you who don't have the required documents to attend the annual shareholder's meeting
How is mgmt and the BOD going to get in to the meeting if you have to show proof of ownership?
Sadly this brilliant mgmt team has pphm stock hitting a new year to date low at $1.32. However this is another great buying opportunity as we are better off now than if we were $50 and under BP control.
I was aware of CVM.... and look at the share price! I don't think their regular sharing of enrollment numbers has helped the share price.
So in other words when you posted there were no other companies that shared enrollment numbers it conveniently was not on your mind. Now it is it didn't help the share price. Hmmmmm
You forgot the good news!
Patriot Scientific Corporation trading at 6 cents MC 22mil
CryoPort, Inc.trading at 40 cents MC 24mil
Ecotality, Inc. trading at 1 cent MC $274,000
Now thats success for CJ
IMO
That is really sad and actually should be a sticky post since it contains actual facts and valid concerns.
Just to refresh peoples memory on a dark day in pphm history. Funny how they say independent perspective. Our COB on at least two penny stock boards and we are supposed to be worth billions.All imo
October 21, 2010
Peregrine Appoints Chairman of the Board and Announces Results From Annual Meeting of Stockholders
TUSTIN, CA, Oct 21, 2010 (MARKETWIRE via COMTEX News Network) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced the appointment of Carlton M. Johnson as chairman of the board of directors. Mr. Johnson has served as a director of Peregrine since 1999 and is also the chair of the audit committee.
"Carl is committed to driving Peregrine's future success in developing our targeted antibodies, and we are pleased to have him assume the added responsibilities as our chairman," said Steven W. King, president and chief executive officer of Peregrine. "A highly involved member of our board, Carl works closely and effectively with our management team while bringing independent perspective for our business decisions."
In addition, Peregrine announced results from its Annual Meeting of Stockholders. Shareholders elected four directors, including Carlton M. Johnson, Steven W. King, David H. Pohl, and Eric S. Swartz, and ratified Ernst & Young LLP as Peregrine's independent public accounting firm for fiscal year 2011. In addition, shareholders approved Peregrine's 2010 Stock Incentive Plan and 2010 Employee Stock Purchase Plan.
Mr. Johnson has been the in-house legal counsel for Roswell Capital Partners, LLC since 1996. He has been admitted to the practice of law in Alabama since 1986, Florida since 1982 and Georgia since 1997. He has been a shareholder in the Pensacola, Florida AV- rated law firm of Smith, Sauer, DeMaria and was President-Elect of the Escambia-Santa Rosa Bar Association, which includes 500 members. He also served on the Florida Bar Young Lawyers Division Board of Governors. Mr. Johnson earned a degree in History and Political Science at Auburn University and Juris Doctor at Samford University, Cumberland School of Law. Mr. Johnson also serves on the board of Patriot Scientific Corporation, CryoPort, Inc., and Ecotality, Inc., all public companies.
About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara(R). Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.
Contact:
Amy Figueroa
Peregrine Pharmaceuticals
(800) 987-8256
info@peregrineinc.com
SOURCE: Peregrine Pharmaceuticals
mailto:info@peregrineinc.com
Copyright 2010 Marketwire, Inc., All rights reserved.
I do not remember one annual where something new was announced, not even the one after Sept 24th, 2012. "We are going to the bottom of this!" was the quote of that year and they went to the bottom of it, but it was not new.
Well you missed the granddaddy of them all when at the shareholders meeting they announced after an exhaustive search and many interviews that they picked Carlton Johnson to be our COB. They didn't even know this news was a material event and had to be PR'd until a shareholder told them they had to! The brilliant mgmt team has been intact since then. All imo.
Time for more wookng as another buying opportunity is presented itself. PPHM now back in the $1.30's. Even with the down market today indices are near all time highs while our brilliant mgmt team has shareholders down over 50% since the reverse split. This despite another one of SK's false statements that pphm tends to flow with the ebb of the market. SK's words have proven meaningless as his we are in talks are synonymous with the boy who cried wolf. Wall Street obviously has turned a deaf ear. All imo.
8am has come and gone once again which means another day has passed for the 2009 catalyst for a Bavi and/or Cotara Partnership. No worries though as ESMO is in process and mgmt is attending as a freebie. Maybe SK has brought along a guest at shareholders expense. This brilliant mgmt team has shareholders down over 50% over 5 years and close to 75% over 10 years but they continue to do a brilliant job. Any day we should all get excited if they move the stock to $1.50. Again another day to feel lucky that we are not a part of Big Pharma and $50 with patients receiving care and count our lucky stars we are at $1.42. All imo.
LOL! Yes hard to get excited and cheer when your team is once again down by 40 points at halftime after finishing last year after year and missing the playoffs for the last 10 years while still employing the same coach and mgmt team that is responsible for the ineptitude. The same mgmt team that picked Ryan Leaf over Peyton Manning because Peyton came from a bigger school and wanted more control over the team (Picking Carlton Johnson over anybody!). Although now the team has employed many free agents that weren't drafted and they are in talks with a "prized" free agent that may be able to win a game or two soon.
Reality is that five years ago stock was at $3.20 and now it is $1.42. All imo.
ESMO 2014 - Brest Cancer - but nothing found from Bavi or PPHM
I am sure this was done on purpose from our Brilliant mgmt team as we have to make sure nobody hears of pphm so that they don't attempt to damage our trials. It is also better to sell ATM shares at lower prices (remember hardly any shares sold at $2.50 and above during 60 million share days) and just remember as shareholders we are lucky the share price is $1.42 instead of $50. We should just be lucky that we didn't make a deal with BP so that they would have their board members on the BOD and that BAVI would actually probably be close to market right now. Five years ago at RS the stock was $3.20 but luckily through the brilliant work of mgmt five years later we sit at $1.42 (Yes not a typo). All imo.
We learnt a lot from that trial.... Guarantee we are well secured this time
So in other words mgmt was not prepared and/or took shortcuts in one of their most important trials? Shouldn't they have learned from the other trial that was supposedly tainted with also Shouldn't they be proactive and not reactive?. It is great that we learned a lot from that trial. Too bad it only cost shareholders huge amounts of dilution and more patients have been dying and there has been at least a two year delay. At least the brilliant mgmt team did not suffer any losses as they actually made more money thru retention bonuses more options at cheaper prices and they continued collected their outrageous compensation. Hard cold facts is at $1.42 not many people believe mgmt has its act together or is brilliant. All imo.
I believe we have security in place...
If true then why weren't the same guards and checkpoints set up in the botched trial? If they did have security in place for the botched trial then it doesn't bode well for this trial. Good thing mgmt is doing a brilliant job. $1.42 hard fact.
Actually closed at $1.42 with a four cent move which now means a long weekend of endless hopium even though last Friday the stock closed at $1.46 after a 7 cent move and a weakend of hopium. One of these days maybe the boy who cried wolf story will be false. All imo.